Vaginal mesh particles ‘could trigger autoimmune response even after removal’

Research has suggested an immunotherapy drug could spare bowel cancer patients the need for surgery (Alamy/PA) -

Microscopic particles left behind by vaginal mesh could continue to trigger the immune system to attack healthy tissue even after the material has been removed, according to researchers.

Experts suggest allergy testing patients before they are fitted with mesh may help to better understand why complications happen in some cases.